Ferro, A., Bae, H. J., Yenokyan, G., Le, Y., McNutt, T., Mian, O., . . . Song, D. Y. (2017). Reductions in prostatic doses are associated with less acute morbidity in patients undergoing Pd-103 brachytherapy: Substantiation of the rationale for focal therapy. Brachytherapy.
Chicago-stil citatFerro, Adam, et al. "Reductions in Prostatic Doses Are Associated With Less Acute Morbidity in Patients Undergoing Pd-103 Brachytherapy: Substantiation of the Rationale for Focal Therapy." Brachytherapy 2017.
MLA-referensFerro, Adam, et al. "Reductions in Prostatic Doses Are Associated With Less Acute Morbidity in Patients Undergoing Pd-103 Brachytherapy: Substantiation of the Rationale for Focal Therapy." Brachytherapy 2017.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.